Caribou Biosciences Inc (CRBU)

03:39 AM

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Caribou Biosciences, Inc. (CRBU) and Encourages Shareholders to Learn More About the Investigation - markets.businessinsider.com

03:39 AM

Apr 05, 2025

Thrivent Financial for Lutherans Acquires 79,636 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World

Apr 05, 2025

Apr 04, 2025

Caribou Biosciences stock hits 52-week low at $0.71 - Investing.com India

Apr 04, 2025

Apr 04, 2025

Caribou Biosciences stock hits 52-week low at $0.71 By Investing.com - Investing.com South Africa

Apr 04, 2025

Apr 03, 2025

Caribou Biosciences, Inc. (CRBU) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - markets.businessinsider.com

Apr 03, 2025

Apr 01, 2025

Caribou Biosciences, Inc. (CRBU) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - markets.businessinsider.com

Apr 01, 2025

Mar 30, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Caribou Biosciences, Inc. (CRBU) And Encourages Investors to Connect - markets.businessinsider.com

Mar 30, 2025

Mar 27, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Caribou Biosciences, Inc. (CRBU) Stockholders to Inquire about Securities Investigation - Markets Insider

Mar 27, 2025

Mar 26, 2025

Caribou Biosciences, Inc. (NASDAQ:CRBU) Receives $10.33 Consensus Target Price from Analysts - Defense World

Mar 26, 2025

Mar 25, 2025

Caribou Biosciences stock hits 52-week low at $0.95 By Investing.com - Investing.com Canada

Mar 25, 2025

Mar 25, 2025

Caribou Biosciences stock hits 52-week low at $0.95 - Investing.com

Mar 25, 2025

Mar 25, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Caribou Biosciences, Inc. (CRBU) and Encourages Investors to Learn More About the Investigation - Markets Insider

Mar 25, 2025

Mar 22, 2025

Caribou Biosciences’ (CRBU) “Buy” Rating Reiterated at HC Wainwright - Defense World

Mar 22, 2025

Mar 20, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Caribou Biosciences, Inc. (CRBU) And Encourages Stockholders to Reach Out - Markets Insider

Mar 20, 2025

Mar 20, 2025

Caribou Biosciences’ SWOT analysis: CRISPR pioneer’s stock faces critical juncture - Investing.com Canada

Mar 20, 2025

Mar 20, 2025

Truist Removes Price Target on Caribou Biosciences, Keeps Buy Rating; Price Target Was $19 - Marketscreener.com

Mar 20, 2025

Mar 19, 2025

US Bancorp DE Buys 26,467 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World

Mar 19, 2025

Mar 18, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Caribou Biosciences, Inc. (CRBU) And Encourages Stockholders to Connect - Markets Insider

Mar 18, 2025

Mar 17, 2025

Caribou Biosciences CEO Rachel E. Haurwitz buys $20,400 in stock By Investing.com - Investing.com Australia

Mar 17, 2025

Mar 17, 2025

Caribou Biosciences CEO Rachel E. Haurwitz buys $20,400 in stock - Investing.com India

Mar 17, 2025

Mar 16, 2025

Caribou Biosciences, Inc. (CRBU) Reports Q4 Loss, Lags Revenue Estimates - MSN

Mar 16, 2025

Mar 16, 2025

Caribou Biosciences, Inc. (CRBU) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - Markets Insider

Mar 16, 2025

Mar 15, 2025

Analysts Remain Bullish on Caribou Biosciences (CRBU) Despite Ongoing Slump in its Shares - Markets Insider

Mar 15, 2025

Mar 13, 2025

Caribou Biosciences stock hits 52-week low at $1 By Investing.com - Investing.com Australia

Mar 13, 2025

Mar 13, 2025

Caribou Biosciences stock hits 52-week low at $1 - Investing.com

Mar 13, 2025

Mar 13, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Caribou Biosciences, Inc. (CRBU) and Encourages Stockholders to Learn More About the Investigation - Markets Insider

Mar 13, 2025

Mar 13, 2025

CRBU FY2029 EPS Reduced by Brookline Capital Management - Defense World

Mar 13, 2025

Mar 12, 2025

Caribou Biosciences Brass Face Investor's Clinical Trials Suit - Law360

Mar 12, 2025

Mar 12, 2025

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences - GuruFocus.com

Mar 12, 2025

Mar 12, 2025

Caribou Biosciences Advances CRISPR Therapies Amid Financial Challenges - TipRanks

Mar 12, 2025

Mar 11, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Caribou Biosciences, Inc. (CRBU) Investors to Inquire about Securities Investigation - Markets Insider

Mar 11, 2025

Mar 11, 2025

RBC Cuts Price Target on Caribou Biosciences to $11 From $14, Keeps Outperform, Speculative Risk - Marketscreener.com

Mar 11, 2025

Mar 10, 2025

Caribou Biosciences reports Q4 EPS (39c), consensus (42c) - TipRanks

Mar 10, 2025

Mar 10, 2025

Caribou Biosciences shares rise on narrower-than-expected Q4 loss By Investing.com - Investing.com Australia

Mar 10, 2025

Mar 10, 2025

Caribou Biosciences shares rise on narrower-than-expected Q4 loss - Investing.com India

Mar 10, 2025

Mar 10, 2025

Caribou Biosciences, Inc. SEC 10-K Report - TradingView

Mar 10, 2025

Mar 10, 2025

Caribou Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - The Manila Times

Mar 10, 2025

Mar 10, 2025

Caribou Biosciences, Inc. Anticipates Clinical Data from CB-010 and CB-011 in H1 2025 Amidst Advancements in Hematologic Malignancies and Autoimmune Disease Therapies - Nasdaq

Mar 10, 2025

Mar 10, 2025

Caribou Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides ... - The Bakersfield Californian

Mar 10, 2025

Mar 08, 2025

Caribou Biosciences, Inc. Sued for Securities Law ViolationsI - GuruFocus.com

Mar 08, 2025

Mar 07, 2025

CARIBOU ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire

Mar 07, 2025

Mar 04, 2025

Caribou Biosciences Leaders Overhyped Cancer Therapy, Suit Says - Bloomberg Law News

Mar 04, 2025

Mar 03, 2025

Caribou Biosciences (CRBU) Expected to Announce Quarterly Earnings on Monday - Defense World

Mar 03, 2025